Evan David Seigerman
Stock Analyst at BMO Capital
(1)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Outperform | 600 640 | 546.18 | 17.18% | 8 | Aug 4, 2025 | |
REPL Replimune Group | Downgrades: Underperform | 27 2 | 4.98 | -59.84% | 4 | Jul 23, 2025 | |
NGNE Neurogene | Maintains: Outperform | 22 26 | 20.36 | 27.7% | 2 | Jun 12, 2025 | |
MRUS Merus | Maintains: Outperform | 96 110 | 64.6 | 70.28% | 1 | May 23, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Outperform | 24 28 | 24.83 | 12.77% | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 10 | 6.58 | 51.98% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 105 64 | 49.85 | 28.39% | 6 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 105 96 | 80.06 | 19.91% | 4 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 208 215 | 198.62 | 8.25% | 7 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 362 346 | 285.1 | 21.36% | 4 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 52 57 | 56.99 | 0.02% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 100 | 17.5 | 471.43% | 2 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 36 | 24.61 | 46.28% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 31 72 | 58.7 | 22.66% | 4 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | 6.21 | -51.69% | 1 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 369 396 | 635.48 | -37.68% | 1 | Sep 6, 2022 |